Lyell Immunopharma, Inc.
COM
CUSIP: 55083R104
FIGI: BBG00RNXFN14
Institutional Holders1
Total Institutional Value$21,301,299
Total Shares Held692,050
Avg Position$21,301,299
Top 5 Holders %100.0%
Alpha-Weighted Score89.0
New Positions+0
Exited Positions-3
Top 15 Institutional Holders by Value
■ New ■ Increased ■ Decreased ■ Unchanged
Institutional Holders — Q4 25
| Manager | Alpha | Flow | Value | Shares | Change |
|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | Elite Conviction | Minimal Flow | $21,301,299 (100.0%) | 692,050 | 120.3% |
Implied Institutional Price History
Estimated from 13F aggregate market value ÷ shares reported across all institutional filers. Reflects quarter-end snapshot, not actual trade prices.
| Quarter | Filers | Institutional Value | Shares Held | Est. Avg Price |
|---|---|---|---|---|
| Q4 25 | 1 | $0.02B | 692,050 | $30.78 |
| Q3 25 | 5 | $0.01B | 2,891,934 | $4.40 |
| Q2 25 | 6 | $0.02B | 2,440,673 | $8.84 |
| Q1 25 | 111 | $0.08B | 153,685,391 | $0.51 |
| Q4 24 | 102 | $0.09B | 151,993,975 | $0.61 |
| Q3 24 | 115 | $0.17B | 132,770,620 | $1.28 |
| Q2 24 | 115 | $0.18B | 134,820,696 | $1.37 |
| Q1 24 | 124 | $0.29B | 138,577,307 | $2.10 |
Source: SEC 13F-HR filings. Implied price = aggregate market value ÷ shares reported. Not investment advice.